SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-012328
Filing Date
2024-02-07
Accepted
2024-02-07 17:33:13
Documents
5
Effectiveness Date
2024-02-07

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-form_s-8.htm S-8 101653
2 EX-5.1 vktx-ex5_1.htm EX-5.1 28751
3 EX-23.1 vktx-ex23_1.htm EX-23.1 4839
4 EX-FILING FEES vktx-exfiling_fees.htm EX-FILING FEES 22537
5 GRAPHIC img246856755_0.jpg GRAPHIC 11202
  Complete submission text file 0000950170-24-012328.txt   174395
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276939 | Film No.: 24605998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)